The emergence of multidrug resistant Acinetobacter species: a major concern in the hospital setting.
Acinetobacter spp. have emerged in recent years as a major cause of nosocomial infections that are associated with significant morbidity and mortality. Developing resistance patterns have prompted the suggestion that we are closer to the end of the antibiotic era with Acinetobacter than with methicillin-resistant Staphylococcus aureus (J Hosp Infect58, 2004, 167).
Hanlon
G W
GW
School of Pharmacy and Biomolecular Sciences, University of Brighton, Moulsecoomb, Brighton, UK. g.w.hanlon@brighton.ac.uk
D000151:Acinetobacter Infections / Q000188:drug therapy / Q000453:epidemiology*; D040981:Acinetobacter baumannii / Q000187:drug effects* / Q000201:enzymology; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D003428:Cross Infection / Q000188:drug therapy / Q000382:microbiology*; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans
D000900:Anti-Bacterial Agents